GlassScriptPhysician profile
Nancy J Cao
NPI 1194703207
$5,407.80
in general payments reported to CMS, 2019-2025
18 companies · $1,967 in 2025
The $1,967 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $103 · 2021: $470 · 2022: $762 · 2023: $746 · 2024: $1,227 · 2025: $1,967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,728 · Consulting Fee: $150 · Education: $63.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,727.71 |
| Consulting Fee | $150.00 |
| Education | $63.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,455.64 | 2022-2025 | Nayzilam, Briviact, Rystiggo |
| Novartis Pharmaceuticals Corporation | $1,122.85 | 2019-2025 | |
| Abbvie INC. | $594.31 | 2021-2025 | Qulipta, Ubrelvy |
| Pfizer INC. | $530.65 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $434.33 | 2022-2025 | |
| Eisai INC. | $223.63 | 2024-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $174.03 | 2022 | |
| Gt Medical Technologies, INC | $159.42 | 2025 | Gammatile |
| Biohaven Pharmaceuticals, INC. | $154.76 | 2021 | |
| Amgen INC. | $114.79 | 2019-2025 | Uplizna |
| Axsome Therapeutics, INC. | $83.03 | 2024-2025 | Sunosi |
| Biogen, INC. | $73.52 | 2019-2021 | |
| Allergan, INC. | $73.50 | 2020 | |
| Neurelis, INC. | $66.40 | 2025 | Valtoco |
| Medtronic, INC. | $63.00 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $39.60 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2021 | |
| Lilly USA, LLC | $14.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Cao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.